Overview
Pigmented paravenous retinochoroidal atrophy (PPRCA), also known as pigmented paravenous chorioretinal atrophy, is a rare, typically non-progressive or slowly progressive retinal disorder characterized by distinctive pigment accumulation and chorioretinal atrophy distributed along the retinal veins in a radiating pattern from the optic disc toward the periphery. The condition primarily affects the eye, specifically the retina and choroid (the vascular layer beneath the retina). The hallmark finding on fundus examination is bone spicule-like pigment clumping adjacent to the retinal veins, accompanied by areas of retinal pigment epithelium (RPE) and choroidal atrophy in a paravenous distribution. Most patients with PPRCA are asymptomatic or have only mild visual complaints, as central vision is often preserved. Some individuals may experience mild visual field defects corresponding to the areas of atrophy, nyctalopia (night blindness), or reduced electroretinogram (ERG) responses. The condition is usually discovered incidentally during routine eye examinations. Visual acuity typically remains good unless the macula becomes involved in advanced cases. The exact etiology of PPRCA remains unclear. Most cases appear to be sporadic, though rare familial cases have been reported. Proposed causes include inflammatory, infectious, or degenerative mechanisms, but none have been definitively established. There is no specific treatment for PPRCA. Management involves regular ophthalmologic monitoring to track any progression and to detect potential complications. The prognosis is generally favorable, as the condition tends to remain stable or progress very slowly over many years.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Pigmented paravenous retinochoroidal atrophy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pigmented paravenous retinochoroidal atrophy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pigmented paravenous retinochoroidal atrophy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pigmented paravenous retinochoroidal atrophy.
Community
No community posts yet. Be the first to share your experience with Pigmented paravenous retinochoroidal atrophy.
Start the conversation →Latest news about Pigmented paravenous retinochoroidal atrophy
No recent news articles for Pigmented paravenous retinochoroidal atrophy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pigmented paravenous retinochoroidal atrophy
What is Pigmented paravenous retinochoroidal atrophy?
Pigmented paravenous retinochoroidal atrophy (PPRCA), also known as pigmented paravenous chorioretinal atrophy, is a rare, typically non-progressive or slowly progressive retinal disorder characterized by distinctive pigment accumulation and chorioretinal atrophy distributed along the retinal veins in a radiating pattern from the optic disc toward the periphery. The condition primarily affects the eye, specifically the retina and choroid (the vascular layer beneath the retina). The hallmark finding on fundus examination is bone spicule-like pigment clumping adjacent to the retinal veins, accom
How is Pigmented paravenous retinochoroidal atrophy inherited?
Pigmented paravenous retinochoroidal atrophy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.